Advanced Biotherapy Inc (791833) SEC Filing 10-Q Quarterly report for the period ending Tuesday, September 30, 2008

Advanced Biotherapy Inc

CIK: 791833

View differences made from one quarter to another to evaluate Advanced Biotherapy Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Advanced Biotherapy Inc.


Assess how Advanced Biotherapy Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Advanced Biotherapy Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2008 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 791833
Form Type: 10-Q Quarterly Report
Accession Number: 0001144204-08-064173
Submitted to the SEC: Fri Nov 14 2008 2:35:13 PM EST
Accepted by the SEC: Fri Nov 14 2008
Period: Tuesday, September 30, 2008
Industry: Commercial Physical And Biological Research

External Resources:

Bookmark the Permalink: